Sanofi Paid $14.6bn In Rebates In 2020; Net Prices Were Down
US Average Aggregate Net Prices Declined 7.8%
Executive Summary
The company released an annual pricing report, showing that Sanofi's US average net prices declined for the fifth year in a row.
You may also be interested in...
Global COVID-19 Vaccine Spending Estimated At $157bn Through 2025 By IQVIA
Vaccine spending projections represent about 2% of total spending on medicines IQVIA said. Increased spending will be partly offset by COIVD-19 disruptions, however.
Janssen US Net Drug Prices Declined 5.7% in 2020; J&J Pushes Rebate Reform
Janssen's net drug prices declined for the fourth year in a row in 2020, while list prices increased 3.8%, according to the company's drug pricing report.
Stock Watch: The Complex Biologics Market Is…Complex
The rise of the biosimilars has been predicted for many years, but the commercial dynamics after complex biologic drugs’ loss of exclusivity suggests that it may not be so straightforward.